Funding for this research was provided by:
Novo Nordisk Fonden (.)
Danish National research foundation (126)
Received: 29 May 2019
Accepted: 31 July 2019
First Online: 9 August 2019
Ethics approval and consent to participate
: Written informed consent was obtained from all participants, and the study was performed in accordance with the ethical guidelines of the 1975 Declaration of Helsinki and approved by the Local Ethical Committee (H-15017350) and the Danish Data Protection Agency.
: Not applicable.
: MG: Travelling grants from Gilead. ADK: Travelling grants from Gilead. JL: No conflicts of interest. KBL: no conflict of interest. AM: Honoraria, lecture fees, and travel support from ViiV and Gilead. BL: No conflict of interest. KFK: No conflict of interests. SDN: Unrestricted research grants from Novo Nordisk Foundation, Lundbeck Foundation, Augustinus Foundation, Rigshospitalet Research Council. Travelling grants from Gilead and GSK/ViiV. Advisory board activity for Gilead and GSK/ViiV.